May 2015 Analysis

Industry Trend Analysis - New Compounds Fill Pipelines As R&D Expenditure Rises - MAY 2015

Pharmaceutical R&D expenditure will continue to rise in 2015, as large firms aim to replace compounds that are facing patent expiry. While not all big pharma will increase R&D spend in 2015 the busy late-stage pipelines and plans for filings of new molecular entities, especially in the immuno-oncology arena, will contribute to higher expenditures.